Literature DB >> 5576331

Antigenic specificities on murine sarcoma cells. Reciprocal relationship between normal transplantation antigens (H-2) and tumor-specific immunogenicity.

G R Haywood, C F McKhann.   

Abstract

Five methylcholanthrene-induced sarcomas were compared for their capacity to (a) absorb monospecific H-2 antisera, (b) induce tumor-specific immunity in syngeneic mice, and (c) metastasize early to the lungs. Comparison of the uptakes of monospecific H-2 antisera by the five different tumors showed that each of the tumors had a high, intermediate, or low surface representation of all of the seven specificities tested. No antigenic specificity was completely absent from any tumor, and no tumor had an unusually large or small amount of any individual specificity. The tumors could be placed in the sequence from one to five with respect to their H-2 antigenicity. The same five tumors were also ranked with respect to their capacity to induce a tumor-specific immune response in syngeneic mice. The tumor-specific immunogenicity had an inverse relationship to the H-2 antigenicity in that highly immunogenic tumors were those that had quantitatively less H-2 antigen on their surface and vice versa. Early metastases to the lung was associated with low levels of tumor-specific immunogenicity and high levels of H-2 antigenicity.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5576331      PMCID: PMC2138927          DOI: 10.1084/jem.133.6.1171

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  IMMUNE LYSIS OF THYMUS AND SPLEEN CELLS OF EMBRYONIC AND NEONATAL MICE.

Authors:  M SCHLESINGER
Journal:  J Immunol       Date:  1965-03       Impact factor: 5.422

2.  Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.

Authors:  G KLEIN; H O SJOGREN; E KLEIN; K E HELLSTROM
Journal:  Cancer Res       Date:  1960-12       Impact factor: 12.701

3.  The distribution in the tissues and the development of H-2 antigens of the mouse.

Authors:  O PIZARRO; G HOECKER; P RUBINSTEIN; A RAMOS
Journal:  Proc Natl Acad Sci U S A       Date:  1961-12-15       Impact factor: 11.205

4.  Concomitant immunity in hamsters bearing DMBA-induced tumor transplants.

Authors:  R N Lausch; F Rapp
Journal:  Int J Cancer       Date:  1969-03-15       Impact factor: 7.396

5.  Selection of an immunoresistant Moloney lymphoma subline with decreased concentration of tumor-specific surface antigens.

Authors:  E M Fenyö; E Klein; G Klein; K Swiech
Journal:  J Natl Cancer Inst       Date:  1968-01       Impact factor: 13.506

6.  Labelling of mouse alloantibody with tritiated dl-alanine.

Authors:  U Hämmerling; N Shigeno; L J Old; E A Boyse
Journal:  Immunology       Date:  1969-12       Impact factor: 7.397

7.  An approach to the mapping of antigens on the cell surface.

Authors:  E A Boyse; L J Old; E Stockert
Journal:  Proc Natl Acad Sci U S A       Date:  1968-07       Impact factor: 11.205

8.  Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro.

Authors:  L J Old; E Stockert; E A Boyse; J H Kim
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

9.  Quantitative studies of the sensitivity of normal and neoplastic mouse cells to the cytotoxic action of isoantibodies.

Authors:  E MOLLER; G MOLLER
Journal:  J Exp Med       Date:  1962-03-01       Impact factor: 14.307

10.  Antigenic structure of cell surfaces. An immunoferritin study of the occurrence and topography of H-2' theta, and TL alloantigens on mouse cells.

Authors:  T Aoki; U Hämmerling; E De Harven; E A Boyse; L J Old
Journal:  J Exp Med       Date:  1969-11-01       Impact factor: 14.307

View more
  14 in total

1.  Collagenolytic activities in methylcholanthrene-induced fibrosarcomas in mice.

Authors:  K R Labrosse; I E Liener
Journal:  Mol Cell Biochem       Date:  1978-05-31       Impact factor: 3.396

2.  Studies on the expression of H-2 antigens in non-metastatic and highly metastatic Friend erythroleukemia cells: correlation with the in vivo behaviour of tumor cells.

Authors:  M Ferrantini; S Pulciani; E Proietti; G Lespinats; A Anastasi; V Ciolli; P Rizza; F Belardelli
Journal:  Clin Exp Metastasis       Date:  1989 Nov-Dec       Impact factor: 5.150

3.  Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells.

Authors:  R L Simmons; A Rios
Journal:  Ann Surg       Date:  1972-08       Impact factor: 12.969

4.  Relation of H-2 expression on murine RCT(+) sarcoma cells to lung colonization and sensitivity to NK cells.

Authors:  K Masuyama; H Ochiai; S Ishizawa; K Tazawa; S Niwayama; M Fujimaki
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

5.  Control of metastatic properties of BL6 melanoma cells by H-2Kb gene: immunological and nonimmunological mechanisms.

Authors:  E Gorelik; M Kim; L Duty; T Henion; U Galili
Journal:  Clin Exp Metastasis       Date:  1993-11       Impact factor: 5.150

Review 6.  Intratumor immunologic heterogeneity.

Authors:  F R Miller
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

7.  In vivo activation of NK cells induces inhibition of lung colonization of H-2 positive and H-2 negative fibrosarcoma tumor clones.

Authors:  I Algarra; M Pérez; J J Gaforio; F Gasca; F Garrido
Journal:  Clin Exp Metastasis       Date:  1994-01       Impact factor: 5.150

8.  Tumor-associated transplantation antigens in immune rejection of mouse malignant cell hybrids.

Authors:  J Jami; E Ritz
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

9.  Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.

Authors:  H G Ljunggren; K Kärre
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

10.  Immunity as the predominant factor determining metastasis by murine lymphomas.

Authors:  G C Davey; G A Currie; P Alexander
Journal:  Br J Cancer       Date:  1979-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.